Zumutor Biologics Inc Announces FDA Clearance of IND Application of ZM008, a Novel Monoclonal Antibody Drug Against Multiple Solid Cancers

BOSTON and BANGALORE. India, Aug. 11, 2023 -- (Healthcare Sales & Marketing Network) -- Zumutor Biologics Inc "Zumutor", a Boston based biopharmaceutical company focused on developing unique novel therapeutics in immuno-oncology (I-O) today anno... Biopharmaceuticals, Oncology, FDA Zumutor Biologics, Tumor Micro Environment
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news